2008
DOI: 10.1016/j.echo.2008.07.019
|View full text |Cite
|
Sign up to set email alerts
|

The Safety of Definity and Optison for Ultrasound Image Enhancement: A Retrospective Analysis of 78,383 Administered Contrast Doses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
150
1
8

Year Published

2009
2009
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 235 publications
(162 citation statements)
references
References 23 publications
3
150
1
8
Order By: Relevance
“…The microbubbles must be stable enough to resist destruction from normal ultrasound power outputs to ensure adequate concentrations for imaging but may need to have the ability to rupture with high mechanical index ultrasound for some techniques to measure myocardial perfusion. 48 Although ultrasound contrast agents are generally considered safe, 49 the FDA issued a black-box warning for Definity and Optison, which, after a 2008 revision, recommends intensive monitoring for patients with pulmonary hypertension or unstable cardiopulmonary conditions and close observation of patients without these conditions. Currently there are no ultrasound contrast agents approved for MCE perfusion imaging, and the FDA considers it to be an experimental procedure.…”
Section: Contrast Agentsmentioning
confidence: 99%
“…The microbubbles must be stable enough to resist destruction from normal ultrasound power outputs to ensure adequate concentrations for imaging but may need to have the ability to rupture with high mechanical index ultrasound for some techniques to measure myocardial perfusion. 48 Although ultrasound contrast agents are generally considered safe, 49 the FDA issued a black-box warning for Definity and Optison, which, after a 2008 revision, recommends intensive monitoring for patients with pulmonary hypertension or unstable cardiopulmonary conditions and close observation of patients without these conditions. Currently there are no ultrasound contrast agents approved for MCE perfusion imaging, and the FDA considers it to be an experimental procedure.…”
Section: Contrast Agentsmentioning
confidence: 99%
“…Multicenter studies have shown that ultrasound contrast agents have an excellent safety profile with incidence of serious adverse events ranging from 0.0086% to 0.031% (24)(25)(26)(27). Furthermore, these contrast agents do not pose nephrotoxicity risks as they are fully excreted via the respiratory tract (28)(29)(30).…”
Section: Discussionmentioning
confidence: 99%
“…Hypersensitivity to octafluoropropane has also been reported. 18 It was recently shown that sonographic contrast agents provided a sensitive method for assessing the vascular distribution in the rotator cuffs of asymptomatic volunteers. 10,11 These studies showed diminished vascularity of the articular portion of the supraspinatus tendon, in keeping with the concept of a critical zone.…”
Section: Discussionmentioning
confidence: 99%